Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Product containing naloxone hydrochloride and pentazocine hydrochloride |
Is a |
Product containing naloxone (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Product containing naloxone hydrochloride and pentazocine hydrochloride |
Is a |
Product containing pentazocine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Product containing naloxone hydrochloride and pentazocine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Chelating agent |
false |
Inferred relationship |
Some |
|
|
Product containing naloxone hydrochloride and pentazocine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Central nervous system agent (substance) |
false |
Inferred relationship |
Some |
|
|
Product containing naloxone hydrochloride and pentazocine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Naloxone hydrochloride |
false |
Inferred relationship |
Some |
|
|
Product containing naloxone hydrochloride and pentazocine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Pentazocine hydrochloride |
false |
Inferred relationship |
Some |
|
|
Product containing naloxone hydrochloride and pentazocine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Pentazocine (substance) |
false |
Inferred relationship |
Some |
|
|
Product containing naloxone hydrochloride and pentazocine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Opiate agonist-antagonist |
false |
Inferred relationship |
Some |
|
|
Product containing naloxone hydrochloride and pentazocine hydrochloride |
Is a |
Product containing pentazocine in oral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
Product containing naloxone hydrochloride and pentazocine hydrochloride |
Is a |
Naloxone-containing product in oral dose form |
false |
Inferred relationship |
Some |
|
|
Product containing naloxone hydrochloride and pentazocine hydrochloride |
Has manufactured dose form |
Oral dose form |
false |
Inferred relationship |
Some |
|
|